This is what needs to be clarified by TK and the company.
As others have said, they have been continuing the analysis since the initial results. The more I think of this something smells off, particularly as they either knew of what was coming and entered into the revised scheme on this condition. Otherwise there needs to be a revision of this independent data confirmation. We need greater understanding of what has taken place both with the first results and now this later result.
If the cause is different strains, I’m unsure how they don’t know the results drop prior to entering into this scheme and independent data confirmation.
If the same test/parameters were applied to the same data set, how does the results vary so much?
Someone needs to explain and be held accountable.
RAP Price at posting:
11.8¢ Sentiment: Buy Disclosure: Held
